Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - ImmunityBio, Inc. | nk-10q_20150930.htm |
| EX-31.2 - EX-31.2 - ImmunityBio, Inc. | nk-ex312_7.htm |
| EX-31.1 - EX-31.1 - ImmunityBio, Inc. | nk-ex311_8.htm |
Exhibit 32.1
CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. § 1350, AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
I, Patrick Soon-Shiong, the chief executive officer of NantKwest, Inc. (the “Company”), certify for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge,
(i) the Quarterly Report of the Company on Form 10-Q for the quarter ended September 30, 2015 (the “Report”), fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
By: |
|
/s/ Patrick Soon-Shiong |
|
|
|
|
Patrick Soon-Shiong |
|
|
|
|
Chief Executive Officer and Chairman (Principal Executive Officer)
Date: November 10, 2015 |
I, Richard Gomberg, the chief financial officer of NantKwest, Inc. (the “Company”), certify for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge,
(i) the Quarterly Report of the Company on Form 10-Q for the quarter ended September 30, 2015 (the “Report”), fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
By: |
|
/s/ Richard Gomberg |
|
|
|
|
Richard Gomberg |
|
|
|
|
Chief Financial Officer (Principal Financial Officer)
Date: November 10, 2015 |